Cannabix Technologies Inc. (BLOZF) 0.4400 $BLOZF
5 Canadian Marijuana Stocks With Recommended Entry Prices
Anthony Cataldo - at Seeking Alpha - Tue Feb 10, 1:33AM CST
A Preliminary Examination Of N=35 Canadian Marijuana Stocks... Eh?
Anthony Cataldo - at Seeking Alpha - Mon Feb 09, 3:20AM CST
Cannabix Technologies Provides Progress Update on its Marijuana Breathalyzer
ACCESSWIRE - Mon Feb 02, 7:06AM CST
The Cannabix Hand-held Marijuana Breathalyzer is being developed to give law enforcement and employers the ability to test for recent consumption of the THC component of marijuana.
Cannabix Provides Alternative to Costly Drug Detection Tactics
ACCESSWIRE - Mon Jan 26, 8:40AM CST
WHITEFISH, MT / ACCESSWIRE / January 26, 2015 / Most drivers are familiar with breathalyzer tests, which quickly and accurately determine how much alcohol someone has consumed. Originally developed in the 1930s, the device determines how much ethanol is in the breath by measuring the electrical current between an anode and cathode. Law enforcement agencies around the world now use the device as both a preliminary screening and evidentiary tool to prosecute drunk drivers.
TWD.VN: 1.980 (-0.020)
Cannabix Announces Plan of Arrangement to Spinout Gold Property
ACCESSWIRE - Mon Jan 05, 6:49PM CST
Image: https://www.thenewswire.com/client_files/logo_773.png Image: https://www.thenewswire.com/images/twitter.png
Cannabix Technologies Director Update
ACCESSWIRE - Wed Dec 31, 2:27PM CST
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabis (MMJ) Breathalyzer Could Follow Vertical Path of Alcohol Breathalyzer
ACCESSWIRE - Tue Dec 02, 8:40AM CST
Whitefish, MT / ACCESSWIRE / December 2, 2014 / The effects of alcohol on a driver are well documented, with motor skills and often decision-making skills decreasing with each drink, subsequently increasing the likelihood of a fatal accident. A field sobriety test (i.e. walking heel-to-toe, follow a pen with eyes, stand on one foot) typically does an ample job at helping police officers identify a driver under the influence of alcohol, which is then typically followed by the tried-and-true alcohol breathalyzer test to pinpoint blood alcohol concentration (BAC). Although some laws and penalties vary from state to state, there is a nationwide standard of drunk driving being defined as BAC at or above 0.08 percent. Technological advancements have made alcohol breathalyzers affordably available to businesses and consumers, like Akers Biosciences' (NASDAQ: AKER) CHUBE and BreathScan products, to estimate BAC. Another portable BAC estimator, Breathometer's eponymous device that operates by attaching it to the audio output of a smart phone, garnered an aggregate $1 million in investments from all five "sharks" in April on the popular CNBC show "Shark Tank," lending to the idea that it is a growing industry against the backdrop of stiffening laws and greater awareness. Breathometer isn't alone in the smart phone breathalyzer space, orders are being taken for FLOOME, a universal smartphone accessory for measuring BAC developed with the help of Proto Labs (NYSE: PRLB).
PRLB: 68.49 (+0.42), AKER: 3.30 (+0.07)
Cannabix Technologies' Dr. Attariwala Quoted in TIME Magazine Article
ACCESSWIRE - Wed Nov 19, 7:07AM CST
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabix Technologies Releases Renderings & Video of Marijuana Breathalyzer
ACCESSWIRE - Mon Nov 17, 9:59AM CST
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabix Marijuana Breathalyzer Could Help Separate Users From Impaired
ACCESSWIRE - Mon Nov 10, 8:48AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Federal Schedule I regulations on medical marijuana (MMJ) and recreational use are changing with each passing day as states continue to hammer out their own policy frameworks, spurred on by sizeable additions to state coffers as a result of tax revenues. Pew Research Center survey data from earlier this year also shows that for the first time since 1969, when only 12% of Americans favored legalization, more than half (54%) the country is now in favor of making marijuana legal. With 23 states and D.C. now having either some form of MMJ legislation, or open recreational use on the books (as in Colorado and Washington), cash-strapped state budget makers are likely looking closely at data points like the Denver Business Journal's analysis of Colorado's recreational market, which forecasts around $70M in tax revenues this fiscal year. In Oregon, where a ballot vote for legalization is set to take place in November, the state's Legislative Revenue Office estimates 2017 tax revenues at around $16M as a result. Recent in-depth analysis by NerdWallet even put the upper limit for Oregon around $100M per annum, and with a nationwide projection of as much as $3.1B, it seems clear that the tax revenue factor could lead to more easing from the feds. On November 4th, Washington D.C. voters looked to join Colorado and Washington State in legalizing adult-use marijuana after backing Initiative 71 at the voting booths. With voters backing the bill 7-to-3, the initiative will permit anyone over the age of 21 to legally possess as much as two ounces of marijuana and to grow up to three marijuana plants at home.
GWPH: 75.20 (+0.39)
Cannabis Stocks Move Lower as Mid-terms Approach
ACCESSWIRE - Tue Nov 04, 8:02AM CST
Whitefish, MT / November 4, 2014 / Cannabis stocks moved lower last week and early this week, according to data from the Marijuana Index(TM). Top gainers included Endexx Corporation (OTC: EDXC), which is trading up more than 35% since last Monday, despite having no recent press releases. Industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) were trading largely even for the week, as of mid-day trading on Monday.
GWPH: 75.20 (+0.39), MGW.VN: 0.035 (-0.005)
Cannabix Announces Plans to Spinout Gold Property
ACCESSWIRE - Thu Oct 30, 7:04AM CDT
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 75.20 (+0.39)
Cannabix Technologies Inc. Approved for DTC Eligibility
ACCESSWIRE - Wed Oct 22, 7:15AM CDT
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabis Stocks Move Lower After Poor Data at GW Pharma
ACCESSWIRE - Mon Oct 20, 9:33AM CDT
Whitefish, MT / ACCESSWIRE / October 20, 2014 / Cannabis stocks moved largely lower over the past week, led by a 12% drop in GW Pharmaceuticals plc (NASDAQ: GWPH). The company's Phase IIA study of GWP42003 - a CBD-based compound - for ulcerative colitis failed to meet the primary endpoint of disease remission. While second endpoints were promising, the drug also showed poor toleration among patients with a number withdrawing.
GWPH: 75.20 (+0.39)
5 Canadian Marijuana Stocks With Recommended Entry Prices
Anthony Cataldo - at Seeking Alpha - Tue Feb 10, 1:33AM CST
A Preliminary Examination Of N=35 Canadian Marijuana Stocks... Eh?
Anthony Cataldo - at Seeking Alpha - Mon Feb 09, 3:20AM CST
Cannabix Technologies Provides Progress Update on its Marijuana Breathalyzer
ACCESSWIRE - Mon Feb 02, 7:06AM CST
The Cannabix Hand-held Marijuana Breathalyzer is being developed to give law enforcement and employers the ability to test for recent consumption of the THC component of marijuana.
Cannabix Provides Alternative to Costly Drug Detection Tactics
ACCESSWIRE - Mon Jan 26, 8:40AM CST
WHITEFISH, MT / ACCESSWIRE / January 26, 2015 / Most drivers are familiar with breathalyzer tests, which quickly and accurately determine how much alcohol someone has consumed. Originally developed in the 1930s, the device determines how much ethanol is in the breath by measuring the electrical current between an anode and cathode. Law enforcement agencies around the world now use the device as both a preliminary screening and evidentiary tool to prosecute drunk drivers.
TWD.VN: 1.980 (-0.020)
Cannabix Announces Plan of Arrangement to Spinout Gold Property
ACCESSWIRE - Mon Jan 05, 6:49PM CST
Image: https://www.thenewswire.com/client_files/logo_773.png Image: https://www.thenewswire.com/images/twitter.png
Cannabix Technologies Director Update
ACCESSWIRE - Wed Dec 31, 2:27PM CST
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabis (MMJ) Breathalyzer Could Follow Vertical Path of Alcohol Breathalyzer
ACCESSWIRE - Tue Dec 02, 8:40AM CST
Whitefish, MT / ACCESSWIRE / December 2, 2014 / The effects of alcohol on a driver are well documented, with motor skills and often decision-making skills decreasing with each drink, subsequently increasing the likelihood of a fatal accident. A field sobriety test (i.e. walking heel-to-toe, follow a pen with eyes, stand on one foot) typically does an ample job at helping police officers identify a driver under the influence of alcohol, which is then typically followed by the tried-and-true alcohol breathalyzer test to pinpoint blood alcohol concentration (BAC). Although some laws and penalties vary from state to state, there is a nationwide standard of drunk driving being defined as BAC at or above 0.08 percent. Technological advancements have made alcohol breathalyzers affordably available to businesses and consumers, like Akers Biosciences' (NASDAQ: AKER) CHUBE and BreathScan products, to estimate BAC. Another portable BAC estimator, Breathometer's eponymous device that operates by attaching it to the audio output of a smart phone, garnered an aggregate $1 million in investments from all five "sharks" in April on the popular CNBC show "Shark Tank," lending to the idea that it is a growing industry against the backdrop of stiffening laws and greater awareness. Breathometer isn't alone in the smart phone breathalyzer space, orders are being taken for FLOOME, a universal smartphone accessory for measuring BAC developed with the help of Proto Labs (NYSE: PRLB).
PRLB: 68.49 (+0.42), AKER: 3.30 (+0.07)
Cannabix Technologies' Dr. Attariwala Quoted in TIME Magazine Article
ACCESSWIRE - Wed Nov 19, 7:07AM CST
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabix Technologies Releases Renderings & Video of Marijuana Breathalyzer
ACCESSWIRE - Mon Nov 17, 9:59AM CST
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabix Marijuana Breathalyzer Could Help Separate Users From Impaired
ACCESSWIRE - Mon Nov 10, 8:48AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Federal Schedule I regulations on medical marijuana (MMJ) and recreational use are changing with each passing day as states continue to hammer out their own policy frameworks, spurred on by sizeable additions to state coffers as a result of tax revenues. Pew Research Center survey data from earlier this year also shows that for the first time since 1969, when only 12% of Americans favored legalization, more than half (54%) the country is now in favor of making marijuana legal. With 23 states and D.C. now having either some form of MMJ legislation, or open recreational use on the books (as in Colorado and Washington), cash-strapped state budget makers are likely looking closely at data points like the Denver Business Journal's analysis of Colorado's recreational market, which forecasts around $70M in tax revenues this fiscal year. In Oregon, where a ballot vote for legalization is set to take place in November, the state's Legislative Revenue Office estimates 2017 tax revenues at around $16M as a result. Recent in-depth analysis by NerdWallet even put the upper limit for Oregon around $100M per annum, and with a nationwide projection of as much as $3.1B, it seems clear that the tax revenue factor could lead to more easing from the feds. On November 4th, Washington D.C. voters looked to join Colorado and Washington State in legalizing adult-use marijuana after backing Initiative 71 at the voting booths. With voters backing the bill 7-to-3, the initiative will permit anyone over the age of 21 to legally possess as much as two ounces of marijuana and to grow up to three marijuana plants at home.
GWPH: 75.20 (+0.39)
Cannabis Stocks Move Lower as Mid-terms Approach
ACCESSWIRE - Tue Nov 04, 8:02AM CST
Whitefish, MT / November 4, 2014 / Cannabis stocks moved lower last week and early this week, according to data from the Marijuana Index(TM). Top gainers included Endexx Corporation (OTC: EDXC), which is trading up more than 35% since last Monday, despite having no recent press releases. Industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) were trading largely even for the week, as of mid-day trading on Monday.
GWPH: 75.20 (+0.39), MGW.VN: 0.035 (-0.005)
Cannabix Announces Plans to Spinout Gold Property
ACCESSWIRE - Thu Oct 30, 7:04AM CDT
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 75.20 (+0.39)
Cannabix Technologies Inc. Approved for DTC Eligibility
ACCESSWIRE - Wed Oct 22, 7:15AM CDT
Image: https://www.thenewswire.com/client_files/logo_773.png
Cannabis Stocks Move Lower After Poor Data at GW Pharma
ACCESSWIRE - Mon Oct 20, 9:33AM CDT
Whitefish, MT / ACCESSWIRE / October 20, 2014 / Cannabis stocks moved largely lower over the past week, led by a 12% drop in GW Pharmaceuticals plc (NASDAQ: GWPH). The company's Phase IIA study of GWP42003 - a CBD-based compound - for ulcerative colitis failed to meet the primary endpoint of disease remission. While second endpoints were promising, the drug also showed poor toleration among patients with a number withdrawing.
GWPH: 75.20 (+0.39)
